{
  "id": 15913246,
  "title": "GSK, Ionis win US approval for first-of-its-kind hepatitis B drug",
  "url": "https://urgent.news/2026/10/21/gsk-ionis-win-us-approval-for-first-of-its-kind-hepatitis-b-drug",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-21T16:03:00.000Z",
  "source": {
    "name": "BioPharma Dive",
    "slug": "biopharma-dive",
    "url": "https://www.biopharmadive.com/news/gsk-ionis-fda-approve-hibsago-chronic-hepatitis-b-bepirovirsen/833541/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Hibsago is viewed as a potential “functional cure” for chronic infections and an important part of the British drugmaker’s goal of reaching £40 billion in annual revenue by 2031.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Endpoints News",
        "title": "GSK gets FDA approval for hepatitis B drug that offers functional cure",
        "url": "https://urgent.news/2026/10/21/gsk-gets-fda-approval-for-hepatitis-b-drug-that-offers-functional-cure",
        "published": "2026-10-21T10:12:55.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}